Galena Biopharma Enters Into Definitive Agreement To License U.S. Rights for Zuplenz Oral Soluble Film - Will Pay $5M In Cash & Stock
July 22, 2014 at 07:06 AM EDT
Galena Biopharma, Inc. (Nasdaq: GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology ...